Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06291493 · ClinicalTrials.gov registry record · NA
Precision Study Measuring Potassium (K) in Capillary Specimens
A NA study of Precision of Potassium (K) Test in Capillary Whole Blood, sponsored by Abbott Point of Care.
- Completed
- Registry status
- NA
- Development phase
- 161
- Enrollment target
- 4
- Study locations
NCT06291493: Completed NA study of Precision of Potassium (K) Test in Capillary Whole Blood, sponsored by Abbott Point of Care.
NCT06291493 is a NA study of Precision of Potassium (K) Test in Capillary Whole Blood that has completed, run by Abbott Point of Care. The registered enrollment target is 161 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (89% lower). The trial reports 4 study locations across 4 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06291493, a NA study of Precision of Potassium (K) Test in Capillary Whole Blood, has completed, sponsored by Abbott Point of Care.
- COMPLETED
- Registry status
- NA
- Development phase
- 161 participants
- Enrollment target
- 4
- Study locations
Study Summary
Assessing precision of i-STAT K test using the IUO i-STAT CG8+ cartridge on the i-STAT 1 Analyzer.
Primary Outcome
Clinical Evaluation of Precision for the Potassium (K) Test in Capillary Specimens using the i-STAT CG8+ Cartridge with the i-STAT 1 Analyzer
Conditions Studied
Interventions
- DIAGNOSTIC_TEST Fingerstick blood draw
Study Locations (4)
Maryland
- University of Maryland, Baltimore (UMD) - Baltimore
Pennsylvania
- Penn State Health Milton S. Hershey Medical Center (Hershey) - Hershey
Washington
- Eastside Research Associates (ERA) - Redmond
Ontario
- Abbott Point of Care (APOC) - Ottawa
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 161 participants |
| Start Date | 2024-05-07 |
| Est. Completion | 2024-09-13 |
| Phase | NA |
What the finished NCT06291493 record still lists
NCT06291493 is an interventional study that assigns participants to a tested intervention. The registered 161 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (89% lower).
The record links to 1 condition, with Precision of Potassium (K) Test in Capillary Whole Blood appearing as the primary indexed condition, and to 1 intervention - of which Fingerstick blood draw is the first listed.
NCT06291493 reports a single indexed study location in Maryland, Pennsylvania, Washington.
Frequently Asked Questions
What is clinical trial NCT06291493 about?
NCT06291493 is a clinical study titled "Precision Study Measuring Potassium (K) in Capillary Specimens". Assessing precision of i-STAT K test using the IUO i-STAT CG8+ cartridge on the i-STAT 1 Analyzer.
What is the current status of trial NCT06291493?
This trial is currently completed. It is a NA study. The enrollment target is 161 participants. The study started on 2024-05-07. Estimated completion is 2024-09-13.
What conditions does trial NCT06291493 study?
This clinical trial studies the following conditions: Precision of Potassium (K) Test in Capillary Whole Blood.
What interventions are being tested in trial NCT06291493?
The interventions under investigation include: Fingerstick blood draw (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT06291493?
This trial is sponsored by Abbott Point of Care, which has 8 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06291493 being conducted?
This trial has 4 study locations across Maryland, Pennsylvania, Washington, Ontario. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06291493's enrollment target sits among peer trials
161 628th of 2000 higher than 1,373 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06391034 · 161 participants · Phase 2
Magnetic Resonance (MR) Imaging With Hyperpolarized 13C-Pyruvate +/- 13C,15N-Urea in Patients With Prostate Cancer
- NCT06546670 · 161 participants · Phase 1
A Phase I/II Study of ITU512 in Healthy Participants and Patients With Sickle Cell Disease
- NCT06616766 · 161 participants · Phase 1
A Phase 1/2, Open-label, Multicenter, FIH Study to Evaluate Safety, Tolerability, PK and Anti-tumor Activity of YH42946
- NCT06752356 · 161 participants · Phase 3
A Study Investigating Intravenous Human Normal Immune Globulin (IGIV) 10% in Subjects With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI